Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an options trading signal again: unusual options activity screeners and strategies. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Meridian Bioscience (VIVO)

Meridian Bioscience (VIVO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,439,747
  • Shares Outstanding, K 43,748
  • Annual Sales, $ 317,900 K
  • Annual Income, $ 71,410 K
  • 60-Month Beta 0.28
  • Price/Sales 4.50
  • Price/Cash Flow 16.04
  • Price/Book 3.91
Trade VIVO with:

Options Overview Details

View History
  • Implied Volatility 30.10% ( +11.49%)
  • Historical Volatility 25.95%
  • IV Percentile 4%
  • IV Rank 16.28%
  • IV High 89.17% on 12/20/21
  • IV Low 18.61% on 08/12/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 31
  • Volume Avg (30-Day) 85
  • Put/Call OI Ratio 0.20
  • Today's Open Interest 5,082
  • Open Int (30-Day) 4,695

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate 0.15
  • Number of Estimates 2
  • High Estimate 0.18
  • Low Estimate 0.12
  • Prior Year 0.23
  • Growth Rate Est. (year over year) -34.78%

Price Performance

See More
Period Period Low Period High Performance
1-Month
31.07 +5.92%
on 07/27/22
33.01 -0.30%
on 08/15/22
+0.41 (+1.26%)
since 07/15/22
3-Month
24.04 +36.90%
on 05/16/22
34.38 -4.26%
on 07/06/22
+8.24 (+33.40%)
since 05/13/22
52-Week
17.20 +91.34%
on 12/15/21
34.38 -4.26%
on 07/06/22
+12.89 (+64.39%)
since 08/13/21

Most Recent Stories

More News
SHAREHOLDER ALERT: Weiss Law Reminds VIVO, NFLX, VMW, and CMAX Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

VIVO : 32.91 (+0.61%)
NFLX : 249.11 (-0.08%)
VMW : 122.42 (+0.38%)
CMAX : 8.00 (-0.50%)
SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates VIVO, ONEM, HNGR

/PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

VIVO : 32.91 (+0.61%)
HNGR : 18.67 (+0.43%)
Meridian Bioscience (VIVO) Meets Q3 Earnings Estimates

Meridian Bioscience (VIVO) delivered earnings and revenue surprises of 0% and 1.45%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

VIVO : 32.91 (+0.61%)
SNES : 0.5703 (-4.95%)
MERIDIAN BIOSCIENCE REPORTS THIRD QUARTER FISCAL 2022 OPERATING RESULTS

/PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the third quarter ended June 30, 2022. Third Quarter Fiscal 2022...

VIVO : 32.91 (+0.61%)
Generation Bio Co. (GBIO) Reports Q2 Loss, Misses Revenue Estimates

Generation Bio Co. (GBIO) delivered earnings and revenue surprises of -4.76% and 100%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

GBIO : 7.92 (+3.80%)
VIVO : 32.91 (+0.61%)
Is SPDR S&P Health Care Equipment ETF (XHE) a Strong ETF Right Now?

Smart Beta ETF report for XHE

XHE : 104.05 (+1.23%)
VIVO : 32.91 (+0.61%)
CYRX : 45.01 (+0.02%)
CERS : 5.13 (-1.91%)
IHI : 55.56 (+0.36%)
MDEV : 20.00 (+0.08%)
Analysts Estimate Meridian Bioscience (VIVO) to Report a Decline in Earnings: What to Look Out for

Meridian Bioscience (VIVO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

VIVO : 32.91 (+0.61%)
OMI : 35.28 (-0.82%)
Meridian Bioscience Receives Re-Authorization from FDA for its Revogene® SARS-CoV-2 Molecular Assay

/PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced...

VIVO : 32.91 (+0.61%)
MERIDIAN BIOSCIENCE INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Meridian Bioscience, Inc. - VIVO

/PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the...

VIVO : 32.91 (+0.61%)
SHAREHOLDER ALERT: Weiss Law Reminds VIVO, NFLX, VMW, and CMAX Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

VIVO : 32.91 (+0.61%)
NFLX : 249.11 (-0.08%)
VMW : 122.42 (+0.38%)
CMAX : 8.00 (-0.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Meridian Bioscience, Inc. is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and biopharmaceutical enabling technologies that help deliver answers. Its products provide accuracy, simplicity and speed...

See More

Key Turning Points

3rd Resistance Point 33.48
2nd Resistance Point 33.24
1st Resistance Point 33.08
Last Price 32.91
1st Support Level 32.68
2nd Support Level 32.44
3rd Support Level 32.28

See More

52-Week High 34.38
Last Price 32.91
Fibonacci 61.8% 27.81
Fibonacci 50% 25.79
Fibonacci 38.2% 23.76
52-Week Low 17.20

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar